{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:44:10Z","timestamp":1793317450164,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The miR-133b, a commonly recognized muscle-specific miRNA, was reported to be deregulated in many kinds of cancers. However, its potential roles in tumorigenesis remain greatly elusive. Herein, we demonstrate that miR-133b is significantly suppressed in human breast cancer specimens, which is reversely correlated to histological grade of the cancer. Ectopic expression of miR-133b suppresses clonogenic ability and metastasis-relevant traits in vitro, as well as carcinogenesis and pulmonary metastasis in vivo. Further studies have identified Sox9, c-MET, and WAVE2 as direct targets of miR-133b, in which Sox9 contributes to all miR-133b-endowed effects including cell proliferation, colony formation, as well as cell migration and invasion in vitro. Moreover, re-expression of Sox9 reverses miR-133b-mediated metastasis suppression in vivo. Taken together, these findings highlight an important role for miR-133b in the regulation of tumorigenesis and metastatic potential of breast cancer and suggest a potential application of miR-133b in cancer treatment.<\/jats:p>","DOI":"10.1038\/s41419-018-0715-6","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T14:51:26Z","timestamp":1530629486000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer"],"prefix":"10.1038","volume":"9","author":[{"given":"Qiu-Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ci-Xiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Na","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Ning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Rong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,3]]},"reference":[{"key":"715_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"N Atlas","year":"2012","unstructured":"Cancer Genome, Atlas, N. Comprehensive molecular portraits of human breast tumours. Nature 490, 61\u201370 (2012).","journal-title":"Nature"},{"key":"715_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta, G. P. & Massague, J. Cancer metastasis: building a framework. Cell 127, 679\u2013695 (2006).","journal-title":"Cell"},{"key":"715_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrc1098","volume":"3","author":"IJ Fidler","year":"2003","unstructured":"Fidler, I. J. Timeline - the pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited. Nat. Rev. Cancer 3, 453\u2013458 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"715_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan, S. & Weinberg, R. A. Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275\u2013292 (2011).","journal-title":"Cell"},{"key":"715_CR5","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1158\/0008-5472.CAN-08-2741","volume":"69","author":"E Charafe-Jauffret","year":"2009","unstructured":"Charafe-Jauffret, E. et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 69, 1302\u20131313 (2009).","journal-title":"Cancer Res."},{"key":"715_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.stem.2010.04.001","volume":"6","author":"R Pang","year":"2010","unstructured":"Pang, R. et al. A subpopulation of CD26(+) cancer stem cells with metastatic capacity in human colorectal cancer. Cell. Stem. Cell. 6, 603\u2013615 (2010).","journal-title":"Cell. Stem. Cell."},{"key":"715_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","volume":"1","author":"PC Hermann","year":"2007","unstructured":"Hermann, P. C. et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell. Stem. Cell. 1, 313\u2013323 (2007).","journal-title":"Cell. Stem. Cell."},{"key":"715_CR8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nrc2622","volume":"9","author":"DX Nguyen","year":"2009","unstructured":"Nguyen, D. X., Bos, P. D. & Massague, J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274\u2013U265 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"715_CR9","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer, C. L. & Weinberg, R. A. A perspective on cancer cell metastasis. Science 331, 1559\u20131564 (2011).","journal-title":"Science"},{"key":"715_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281\u2013297 (2004).","journal-title":"Cell"},{"key":"715_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215\u2013233 (2009).","journal-title":"Cell"},{"key":"715_CR12","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1242\/dev.02073","volume":"132","author":"I Alvarez-Garcia","year":"2005","unstructured":"Alvarez-Garcia, I. & Miska, E. A. MicroRNA functions in animal development and human disease. Development 132, 4653\u20134662 (2005).","journal-title":"Development"},{"key":"715_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin, G. A. & Croce, C. M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857\u2013866 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"715_CR14","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.cell.2009.07.011","volume":"138","author":"Y Shimono","year":"2009","unstructured":"Shimono, Y. et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138, 592\u2013603 (2009).","journal-title":"Cell"},{"key":"715_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ncb2024","volume":"12","author":"L Ma","year":"2010","unstructured":"Ma, L. et al. miR-9, a MYC\/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol. 12, 247\u2013256 (2010).","journal-title":"Nat. Cell Biol."},{"key":"715_CR16","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.cell.2009.03.047","volume":"137","author":"S Valastyan","year":"2009","unstructured":"Valastyan, S. et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137, 1032\u20131046 (2009).","journal-title":"Cell"},{"key":"715_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ccr.2012.11.019","volume":"23","author":"S Ryu","year":"2013","unstructured":"Ryu, S. et al. Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration. Cancer Cell. 23, 63\u201376 (2013).","journal-title":"Cancer Cell."},{"key":"715_CR18","doi-asserted-by":"publisher","first-page":"8721","DOI":"10.1073\/pnas.0602831103","volume":"103","author":"PK Rao","year":"2006","unstructured":"Rao, P. K., Kumar, R. M., Farkhondeh, M., Baskerville, S. & Lodish, H. F. Myogenic factors that regulate expression of muscle-specific microRNAs. Proc. Natl Acad. Sci. USA 103, 8721\u20138726 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"715_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cell.2011.09.028","volume":"147","author":"M Cesana","year":"2011","unstructured":"Cesana, M. et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147, 358\u2013369 (2011).","journal-title":"Cell"},{"key":"715_CR20","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/CIRCULATIONAHA.107.758672","volume":"118","author":"L Xiao","year":"2008","unstructured":"Xiao, L. et al. Feedback remodeling of cardiac potassium current expression: a novel potential mechanism for control of repolarization reserve. Circulation 118, 983\u2013992 (2008).","journal-title":"Circulation"},{"key":"715_CR21","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.biocel.2009.03.002","volume":"42","author":"WH Townley-Tilson","year":"2010","unstructured":"Townley-Tilson, W. H., Callis, T. E. & Wang, D. MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease. Int. J. Biochem. Cell. Biol. 42, 1252\u20131255 (2010).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"715_CR22","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1140481","volume":"317","author":"J Kim","year":"2007","unstructured":"Kim, J. et al. A microRNA feedback circuit in midbrain dopamine neurons. Science 317, 1220\u20131224 (2007).","journal-title":"Science"},{"key":"715_CR23","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1124\/mol.110.066837","volume":"78","author":"FM Sanchez-Simon","year":"2010","unstructured":"Sanchez-Simon, F. M., Zhang, X. X., Loh, H. H., Law, P. Y. & Rodriguez, R. E. Morphine regulates dopaminergic neuron differentiation via miR-133b. Mol. Pharmacol. 78, 935\u2013942 (2010).","journal-title":"Mol. Pharmacol."},{"key":"715_CR24","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/ncb2612","volume":"14","author":"M Trajkovski","year":"2012","unstructured":"Trajkovski, M., Ahmed, K., Esau, C. C. & Stoffel, M. MyomiR-133 regulates brown fat differentiation through Prdm16. Nat. Cell Biol. 14, 1330\u20131335 (2012).","journal-title":"Nat. Cell Biol."},{"key":"715_CR25","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.cmet.2013.01.004","volume":"17","author":"H Yin","year":"2013","unstructured":"Yin, H. et al. MicroRNA-133 controls brown adipose determination in skeletal muscle satellite cells by targeting Prdm16. Cell. Metab. 17, 210\u2013224 (2013).","journal-title":"Cell. Metab."},{"key":"715_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.18632\/oncotarget.424","volume":"3","author":"N Nohata","year":"2012","unstructured":"Nohata, N., Hanazawa, T., Enokida, H. & Seki, N. microRNA-1\/133a and microRNA-206\/133b clusters: dysregulation and functional roles in human cancers. Oncotarget 3, 9\u201321 (2012).","journal-title":"Oncotarget"},{"key":"715_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4161\/cbt.10.2.12186","volume":"10","author":"G Hu","year":"2010","unstructured":"Hu, G. et al. miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo. Cancer Biol. Ther. 10, 190\u2013197 (2010).","journal-title":"Cancer Biol. Ther."},{"key":"715_CR28","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s13277-012-0609-7","volume":"34","author":"D Wen","year":"2013","unstructured":"Wen, D. et al. miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer. Tumour Biol. 34, 793\u2013803 (2013).","journal-title":"Tumour Biol."},{"key":"715_CR29","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.bbrc.2009.07.143","volume":"388","author":"M Crawford","year":"2009","unstructured":"Crawford, M. et al. MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. Biochem. Biophys. Res. Commun. 388, 483\u2013489 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"715_CR30","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1002\/ijc.25284","volume":"127","author":"M Kano","year":"2010","unstructured":"Kano, M. et al. miR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int. J. Cancer 127, 2804\u20132814 (2010).","journal-title":"Int. J. Cancer"},{"key":"715_CR31","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.1073\/pnas.72.11.4435","volume":"72","author":"SI Shin","year":"1975","unstructured":"Shin, S. I., Freedman, V. H., Risser, R. & Pollack, R. Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc. Natl. Acad. Sci. USA 72, 4435\u20134439 (1975).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"715_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrc2619","volume":"9","author":"MS Nicoloso","year":"2009","unstructured":"Nicoloso, M. S., Spizzo, R., Shimizu, M., Rossi, S. & Calin, G. A. MicroRNAs--the micro steering wheel of tumour metastases. Nat. Rev. Cancer 9, 293\u2013302 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"715_CR33","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1038\/onc.2011.561","volume":"31","author":"W Qin","year":"2012","unstructured":"Qin, W. et al. MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways. Oncogene 31, 4067\u20134075 (2012).","journal-title":"Oncogene"},{"key":"715_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10549-016-4013-7","volume":"160","author":"A Lanczky","year":"2016","unstructured":"Lanczky, A. et al. miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients. Breast Cancer Res. Treat. 160, 439\u2013446 (2016).","journal-title":"Breast Cancer Res. Treat."},{"key":"715_CR35","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.cell.2009.02.005","volume":"136","author":"A Ventura","year":"2009","unstructured":"Ventura, A. & Jacks, T. MicroRNAs and cancer: short RNAs go a long way. Cell 136, 586\u2013591 (2009).","journal-title":"Cell"},{"key":"715_CR36","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1242\/dev.01087","volume":"131","author":"MC Chaboissier","year":"2004","unstructured":"Chaboissier, M. C. et al. Functional analysis of Sox8 and Sox9 during sex determination in the mouse. Development 131, 1891\u20131901 (2004).","journal-title":"Development"},{"key":"715_CR37","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1101\/gad.1017802","volume":"16","author":"H Akiyama","year":"2002","unstructured":"Akiyama, H., Chaboissier, M. C., Martin, J. F., Schedl, A. & de Crombrugghe, B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16, 2813\u20132828 (2002).","journal-title":"Genes Dev."},{"key":"715_CR38","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1101\/gad.259003","volume":"17","author":"CC Stolt","year":"2003","unstructured":"Stolt, C. C. et al. The Sox9 transcription factor determines glial fate choice in the developing spinal cord. Genes Dev. 17, 1677\u20131689 (2003).","journal-title":"Genes Dev."},{"key":"715_CR39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.devcel.2004.12.010","volume":"8","author":"M Cheung","year":"2005","unstructured":"Cheung, M. et al. The transcriptional control of trunk neural crest induction, survival, and delamination. Dev. Cell. 8, 179\u2013192 (2005).","journal-title":"Dev. Cell."},{"key":"715_CR40","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1136\/gutjnl-2014-307075","volume":"64","author":"A Grimont","year":"2015","unstructured":"Grimont, A. et al. SOX9 regulates ERBB signalling in pancreatic cancer development. Gut 64, 1790\u20131799 (2015).","journal-title":"Gut"},{"key":"715_CR41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11060-006-9180-7","volume":"80","author":"U Kordes","year":"2006","unstructured":"Kordes, U. & Hagel, C. Expression of SOX9 and SOX10 in central neuroepithelial tumor. J. Neurooncol. 80, 151\u2013155 (2006).","journal-title":"J. Neurooncol."},{"key":"715_CR42","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747\u2013752 (2000).","journal-title":"Nature"},{"key":"715_CR43","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.cell.2012.02.008","volume":"148","author":"W Guo","year":"2012","unstructured":"Guo, W. et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 148, 1015\u20131028 (2012).","journal-title":"Cell"},{"key":"715_CR44","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/sj.onc.1208177","volume":"24","author":"S Kurisu","year":"2005","unstructured":"Kurisu, S., Suetsugu, S., Yamazaki, D., Yamaguchi, H. & Takenawa, T. Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells. Oncogene 24, 1309\u20131319 (2005).","journal-title":"Oncogene"},{"key":"715_CR45","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/jcb.26334","volume":"119","author":"J Wang","year":"2018","unstructured":"Wang, J. et al. SH3BP1-induced Rac-Wave2 pathway activation regulates cervical cancer cell migration, invasion, and chemoresistance to cisplatin. J. Cell. Biochem. 119, 1733\u20131745 (2018).","journal-title":"J. Cell. Biochem."},{"key":"715_CR46","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1158\/1078-0432.CCR-05-2566","volume":"12","author":"S Semba","year":"2006","unstructured":"Semba, S. et al. Coexpression of actin-related protein 2 and Wiskott-Aldrich syndrome family verproline-homologous protein 2 in adenocarcinoma of the lung. Clin. Cancer Res. 12, 2449\u20132454 (2006).","journal-title":"Clin. Cancer Res."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0715-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0715-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0715-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:11:07Z","timestamp":1671538267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0715-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7]]}},"alternative-id":["715"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0715-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]},"assertion":[{"value":"6 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"752"}}